Thursday, July 27, 2017 12:14:45 PM
"Our shareholders have been very committed and observe that the Company is entering an exciting growth phase regarding the development of PRP, in addition to the recent announcement of plans to expand our product pipeline through our POP1 joint research program," said James Nathanielsz, Propanc Biopharma's Chief Executive Officer. "We are working closely with investment advisors on our future plans for long term financing and restructuring the balance sheet, going forward, so we can work towards an up-listing to a national exchange in the future."
What he is saying is idiot-sheep investors (including me) have given us blindly their money and we have not even delivered shit wrapped in shiny paper.
"So we can work towards an up-listing to a national exchange in the future?"
Was that not the same plan when the RS was done and now you have gone below the price to up list?
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM